Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cystic fibrosis
cystic fibrosis
ReCode Raises $260M in Series B Financing to Advance Lead Programs
ReCode Raises $260M in Series B Financing to Advance Lead Programs
BioSpace
ReCode Therapeutics
funding
primary ciliary dyskinesia
cystic fibrosis
Flag link:
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
Yahoo/Reuters
Vertex Pharmaceuticals
cystic fibrosis
earnings
Flag link:
ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients
ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients
BioSpace
cystic fibrosis
ReCode
Vertex Pharmaceuticals
4DMT
Flag link:
First Wave completes patient screening in trial of cystic fibrosis therapy
First Wave completes patient screening in trial of cystic fibrosis therapy
Clinical Trials Arena
First Wave Biopharma
adrulipase
clinical trials
cystic fibrosis
Flag link:
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
infants
Flag link:
Spotlight – Cystic fibrosis developers take a deep breath
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
Flag link:
‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
Stat
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
patients
Flag link:
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics
Fierce Pharma
Vertex Pharmaceuticals
drug pricing
activists
Trikafta
cystic fibrosis
Flag link:
First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis
First Wave BioPharma to initiate trial of adrulipase for cystic fibrosis
Clinical Trials Arena
First Wave Biopharma
clinical trials
cystic fibrosis
FDA
adrulipase
Flag link:
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Drugs.com
phages
clinical trials
NIH
cystic fibrosis
Adaptive Phage Therapeutics
Flag link:
Why Vertex Pharmaceuticals' Shares Rose 2.8% in September
Why Vertex Pharmaceuticals' Shares Rose 2.8% in September
Motley Fool
Vertex Pharmaceuticals
Trikafta
R&D
cystic fibrosis
Flag link:
Where Will Vertex Pharmaceuticals Be in 1 Year?
Where Will Vertex Pharmaceuticals Be in 1 Year?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
kidney disease
Flag link:
Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis
Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis
BioSpace
Sionna Therapeutics
funding
cystic fibrosis
Vertex Pharmaceuticals
OrbiMed
Flag link:
Vertex’s Robust Pipeline is Ramping Up for Another Big Year
Vertex’s Robust Pipeline is Ramping Up for Another Big Year
BioSpace
Vertex Pharmaceuticals
cystic fibrosis
sickle cell disease
type 1 diabetes
Flag link:
Vertex strikes agreement with Australia for cystic fibrosis pill, ending high-profile standoff
Vertex strikes agreement with Australia for cystic fibrosis pill, ending high-profile standoff
Endpoints
Vertex Pharma
cystic fibrosis
Australia
Trikafta
Flag link:
New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases
New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases
Endpoints
Congruence Therapeutics
funding
OrbiMed
Vertex Pharmaceuticals
protein misfolding
cystic fibrosis
Flag link:
3 Clinical Trials to Watch in the First Half of 2022
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
Flag link:
JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch
JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch
Fierce Pharma
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2022
Trikafta
Flag link:
Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments
Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments
BioPharma Dive
patient advocacy groups
Flagship Pioneering
Moderna Therapeutics
cystic fibrosis
Flag link:
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-880
type 1 diabetes
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »